You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

COSMEGEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cosmegen patents expire, and what generic alternatives are available?

Cosmegen is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in COSMEGEN is dactinomycin. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dactinomycin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cosmegen

A generic version of COSMEGEN was approved as dactinomycin by EUGIA PHARMA on November 9th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for COSMEGEN?
  • What are the global sales for COSMEGEN?
  • What is Average Wholesale Price for COSMEGEN?
Summary for COSMEGEN
Drug patent expirations by year for COSMEGEN
Drug Prices for COSMEGEN

See drug prices for COSMEGEN

Recent Clinical Trials for COSMEGEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Pediatric Cancer FoundationPhase 2
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
Tufts Medical CenterPhase 3

See all COSMEGEN clinical trials

Pharmacology for COSMEGEN

US Patents and Regulatory Information for COSMEGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare COSMEGEN dactinomycin INJECTABLE;INJECTION 050682-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.